This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Purdue Research Foundation. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Yawo Mondjinou: Innovator in Polyrotaxanes
Introduction
Yawo Mondjinou is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of polyrotaxanes, particularly in their applications for medical treatments and imaging techniques. With a total of 3 patents, his work is paving the way for advancements in therapeutic methods.
Latest Patents
Yawo Mondjinou's latest patents include innovative approaches to polyrotaxanes. One of his patents focuses on "Polyrotaxanes bearing mixed cyclodextrin species and uses thereof." This invention encompasses various embodiments directed towards polyrotaxanes that comprise a poloxamer core and at least one cyclodextrin. These polyrotaxanes are designed for treating Niemann-Pick type C (NPC) and for imaging applications, such as MRI. Another patent, titled "Therapeutic and imaging compositions and uses thereof," shares similar themes, emphasizing the therapeutic potential and imaging capabilities of these polyrotaxanes.
Career Highlights
Yawo Mondjinou is affiliated with the Purdue Research Foundation, where he continues to explore and develop his innovative ideas. His work is characterized by a strong focus on the intersection of chemistry and medicine, aiming to address complex health issues through novel solutions.
Collaborations
Yawo collaborates with David H. Thompson, enhancing the research and development efforts in their field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving impactful results.
Conclusion
Yawo Mondjinou's contributions to the field of polyrotaxanes highlight his role as a significant inventor. His innovative patents and collaborations are set to make a lasting impact on therapeutic and imaging technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
